◀ Back to STAT3
JUN — STAT3
Pathways - manually collected, often from reviews:
-
OpenBEL Selventa BEL large corpus:
FAS
→
Complex of JUN-STAT3
(decreases)
Evidence: Downregulation of FAS expression is a common event during tumor progression and has been correlated with resistance to radiation or drug-induced cell death. Importantly, STAT3 binds directly to the FAS promoter in association with JUN to suppress the transcription of the death receptor.
-
NCI Pathway Database IL6-mediated signaling events:
STAT3 (dimer ) complex (STAT3)
→
AP1 complex (FOS-JUN)
(transcription, activates)
Schumann et al., Mol Cell Biol 1996*
Evidence: mutant phenotype, reporter gene, physical interaction
-
NCI Pathway Database IL6-mediated signaling events:
STAT3 (dimer ) complex (STAT3)
→
AP1 complex (FOS-JUN)
(transcription, activates)
Bugno et al., Nucleic Acids Res 1995*
Evidence: mutant phenotype, physical interaction, other species
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Turkson et al., Mol Cell Biol 1999
(Cell Transformation, Neoplastic...) :
Requirement for Ras/Rac1 mediated p38 and
c-Jun N-terminal kinase signaling in
Stat3 transcriptional activity induced by the Src oncoprotein
Higashi et al., Genes Cells 2004
(MAP Kinase Signaling System) :
In contrast, concomitant stimulation of the
STAT3 signal and a MEK/Erk-signal markedly
increased AP-1 activity with enhanced c-Fos expression
Ogunwobi et al., Int J Colorectal Dis 2007
(Colonic Neoplasms) :
Activation of JAK2 was followed by activation and nuclear translocation of
STAT3 and JNK activation
led to increased
activator protein 1 (AP-1) transcriptional activity
Gazi et al., Clin Chim Acta 2007
(Prostatic Neoplasms) :
Interestingly, although sodium selenite did not show effect on activation of both
STAT3 and ERK1/2 in the presence of IL-6, an increased expression of
c-Jun was
detected in cells after treatment with sodium selenite
Reipschläger et al., J Biol Chem 2012
:
RhoA dependent
STAT3 stimulation
requires ROCK and
Jun kinase activation as well as AP1 induced protein synthesis
Kwon et al., J Immunol 2012
:
PKC-? mediated activation of the
Stat3 promoter was
inhibited by dominant negative
AP-1 and I?B kinase-ß, but stimulated by WT AP-1 and I?B kinase-ß, suggesting that PKC-? stimulates Stat3 transcription via the AP-1 and NF-?B pathways
Lu et al., J Dermatol 2013
:
Importantly,
JUN may
regulate activating transcription factor 3 expression to involve cell proliferation process ; STAT1 and
STAT3 can inhibit tissue inhibitor of metalloproteinases-3 expression to modulate the cell adhesion molecule pathway ; NF-?B and E2F1 can downregulate cyclin D1, but upregulate proliferating cell nuclear antigen expression to promote the cell cycle pathway
Wei et al., Acta Pharmacol Sin 2013
:
Furthermore, the treatment selectively prevented the activation of MAPKs, AKT and transcription factor
AP-1 component c-Jun, but not the recruitment of TRAF6 or the
activation of
JAK2/STAT3